Lv1
70 积分 2023-08-29 加入
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer
1个月前
已关闭
Prognostic Implications of Immunohistochemical Biomarkers in Non-muscle-invasive Blad Cancer and Muscle-invasive Bladder Cancer
1个月前
已完结
FOXP3/TLS; a prognostic marker in patients with bladder carcinoma without muscle invasion
1个月前
已完结
Expression of Glucocorticoid Receptor and FOXO1/phospho-FOXO1 in Bladder Cancer as Independent Prognosticators
1个月前
已完结
Adhesion GPR123 is an indicator for recurrence and prognosis in bladder cancer
1个月前
已完结
Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes
2个月前
已完结
Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes
2个月前
已关闭
Favorable 99mTc-FAPI-46 Uptake in Primary Mucinous Adenocarcinoma of the Bladder
4个月前
已关闭
Primary Adenocarcinoma of the Urinary Tract and Its Precursors: Diagnostic Criteria and Classification
5个月前
已完结
皖公网安备34019202002308
